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High vibration perception threshold and autonomic dysfunc-
tion in hemodialysis patients with intradialysis hypotension.
Background. Intradialysis hypotension is a common prob-
lem among hemodialysis patients. Some studies have shown that
autonomic neuropathy could be a major cause of intradialysis
hypotension, whereas others have not. Furthermore, whether
there are parallel changes in the autonomic nervous system
and somatic nerves remains unclear.
Methods. We investigated the autonomic and peripheral
nervous functions of 12 chronic hemodialysis patients who suf-
fered from intradialysis hypotension, and of 12 age- and sex-
matched hemodialysis patients who had stable blood pressure
during hemodialysis. We used spectral analysis of their heart
rate variability and systemic vascular resistance to evaluate auto-
nomic functions. Vibrameter and nerve conduction studies to
assess peripheral nervous function were also performed. Low-
frequency/high-frequency ratio power index was used as a sur-
rogate of sympathovagal balance.
Results. The power index rose progressively in the control
group and reached significantly high levels at hour 4 compared
to the basal values (3.7 0.5 vs. 2.1 0.3; P 0.05). However
in the group prone to hypotension, the power index remained
almost unchanged. In addition, their systemic vascular resis-
tance was lower than that in the control group (13.7  1.8 vs.
22.3  2.6 Wood units; P  0.05). The vibration perception
thresholds of the index finger and great toe were significantly
higher in the group prone to hypotension (4.7  0.7 vs. 2.2 
0.3 vibration units and 3.1  0.4 vs. 1.5  0.2 vibration units,
respectively; both P  0.05).
Conclusion. We found that more severe damage to auto-
nomic and peripheral nervous system occurred in patients
prone to hypotension.
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Intradialysis hypotension is a frustrating and disabling
complication of hemodialysis and has been reported to
occur in as many as 25% to 50% of patients [1]. The
pathogenesis of intradialysis hypotension is multifacto-
rial, including patient-related factors, such as cardiac per-
formance, integrity of the cardiovascular reflex control,
and factors related to the dialysis procedures [2]. Some
researchers have ascribed the cause of intradialysis hypo-
tension to autonomic dysfunction because there should
be a balance between the central hypovolemia caused
by ultrafiltration and the compensation of the autonomic
nervous system [3]. However, other researchers found
no such association [4]. Moreover, since the impairments
of the peripheral nervous system and autonomic nervous
system were found in some of the patients with chronic
uremia [5, 6], it may be reasonable to assume that patients
with intradialysis hypotension would also have more se-
vere damage in the peripheral nervous system. The aim
of our study was to evaluate whether intradialysis hypo-
tension was associated with autonomic dysfunction alone
or extensive generalized polyneuropathy involving both
the peripheral and autonomic systems.
Because spectral analysis of the heart rate variability
(HRV) is a sensitive and well-established tool for investi-
gating the autonomic nervous system [7], we performed
spectral analysis of heart rate variability to assess the
autonomic nervous function in terms of sequential changes
of the balance between sympathetic and parasympathetic
activities. In addition, we also measured systemic vascu-
lar resistance (SVR) using echocardiograms at the end
of hemodialysis.
Although nerve conduction velocity (NCV) study has
been commonly used to evaluate the peripheral nervous
function, vibration perception threshold (VPT) was re-
ported to be a more reliable and sensitive method to
assess uremic peripheral polyneuropathy, and it reflected
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the severity of peripheral neuropathy [8–10]. Thus, we
checked both the VPT and NCV to evaluate the motor
and sensory nervous systems. With the findings of our
study, the pathophysiology of intradialysis hypotension
and uremic polyneuropathy might be further unveiled.
METHODS
Patients
Two groups of chronic hemodialysis patients were en-
rolled in this study. The first group consisted of 12 hypo-
tension-prone patients, 4 women and 8 men, with a mean
age of 61.6  5.1 years (28–83 years). The underlying
diseases of renal failure were chronic glomerulonephritis
in 6 patients, chronic interstitial nephritis in 5 patients,
and nephrosclerosis in 1 patient. Intradialysis hypoten-
sion was defined as a fall of systolic arterial blood pres-
sure to below 90 mm Hg with a drop of blood pressure
of more than 20 mm Hg, and the appearance of nausea,
vomiting, or muscle cramps. Hemodialysis patients who
suffered from intradialysis hypotensive episodes in at
least 50% of the dialysis sessions during the 2 months
before the study were enrolled as study group. The con-
trol group consisted of 12 age- and sex-matched hemodi-
alysis patients who had not experienced any hemody-
namic events during the same period. The underlying
diseases of renal failure in the control group were chronic
interstitial nephritis in 7 patients, chronic glomerulone-
phritis in 3 patients, and gouty nephropathy in 2 patients.
All of the patients were treated 3 times a week for 4
hours with diacetyl-cuprophan dialyzers of a 1.7 m2 sur-
face area, blood flow rates of 200 to 250 mL/min, and a
dialysate flow rate of 500 mL/min. The dialysate compo-
sition was Na 140 mEq/L; K 2 mEq/L; Ca2 3.5 mEq/L;
HCO3 35 mEq/L; and glucose 200 mg/dL. The dialysate
temperature was kept at 36.5C. The dry weights of our
patients were set by clinical assessment and by trial and
error. All the intradialytic hypotensions of the hypoten-
sion-prone group could not be resolved by increasing
dry weight. The ultrafiltration rate was held constant
during the treatment. Patients with diabetes mellitus, con-
gestive heart failure (more severe than New York Heart
Association Functional Class II), and on medications
that may affect the cardiovascular or autonomic nervous
system were excluded from this study. The protein cata-
bolic rate and general nutritional states were similar be-
tween the two groups. All patients complied well with
the fluid restriction recommendations and maintained
their interdialysis weight gain of less than 1 kg per day
and less than 5% of post-dialysis dry weight between
two consecutive hemodialysis sessions. All procedures
were performed in the afternoon from 1:00 pm to 5:00 pm.
The local ethics committee approved the study protocols
and all patients gave written informed consent.
Nerve conduction studies
NCV studies were conducted using a Viking IV Elec-
tromyographer (Nicolet, Madison, WI, USA). We chose
the peroneal and tibial nerves to represent the motor
component, and the sural nerve to represent the sensory
component. Motor conduction studies of the peroneal
and tibial nerves were conducted with surface electrodes
arranged in belly-tendon fashion. The electrodes were
placed over the extensor digitorum brevis muscles for the
peroneal nerve and over the abductor hallucis muscle for
the tibial nerve. In antidromic sensory conduction studies,
sural electrodes were placed over the lateral malleoli. Ac-
tive and reference pickup electrodes were placed 3 cm
apart. Supramaximal stimuli were applied percutaneously
with a hand-held bipolar nerve stimulator. The stimula-
tion sites of the peroneal, tibial, and sural nerves were
at the ankle, about 8 and 14 cm from the recording elec-
trodes, respectively. The amplitudes of the compound mo-
tor action potential (CMAP) and sensory nerve action
potential (SNAP) were automatically measured from the
baseline to the negative peak. We recorded distal latency
(DL) to onset, motor nerve conduction velocities (MNCV)
and CMAP amplitude of the peroneal and tibital nerves,
as well as distal latency to onset of take-off and SNAP
amplitude of the sural nerve.
Vibration perception thresholds
VPT determinations were performed immediately after
completion of nerve conduction study using the Vibra-
tion II (Sensortec, Inc., Clifton, NJ, USA). The vibration
stimulus was delivered at a constant frequency of 120 Hz.
By decreasing the output voltage, the amplitude of the
vertical excursions of the vibrating rod was simultaneously
reduced. The output voltage was displayed in “vibration”
units (VU) as a digital readout. VU determinations were
carried out using the “two-alternative, forced-choice”
method, in which the patient was required to identify
which of the two rubber rods (“A” or “B”) was vibrating
after a randomized A/B sequence at progressively de-
creasing VU levels. The study was terminated upon the
fifth error. The required time to perform the study, in-
cluding patient instruction, was generally less than 15
minutes. VU measurements were taken from the pulp
of the index finger and great toe, from the same extremity
on which the NCV studies were performed. The VPT
was calculated from the 10 VU values representing the
5 errors and 5 lowest correct scores. The highest and
lowest VU values were eliminated, and the mean of the
remaining 8 VU values represented the VPT.
Heart rate variability analysis and autonomic
function assessment
We checked blood pressure 10 minutes before punc-
turing, at the beginning of dialysis, every 15 minutes
during hemodialysis, and at the end of hemodialysis. We
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Table 1. General characteristics of patients
Hypotension- Control
Patient characteristics prone group group P value
Patient number 12 12 NS
Age year 61.65.1 60.55.0 NS
Male/female 8/4 8/4 NS
Duration of dialysis months 60.111.1 51.68.6 NS
Body height cm 155.42.4 155.71.8 NS
Body weight kg 61.42.0 59.22.1 NS
Body mass index 25.50.9 24.40.7 NS
Ultrafiltration rate % 3.50.4 4.20.2 NS
Serum albumin g/dL 3.90.1 4.00.2 NS
Serum prealbumin mg/dL 33.02.8 34.71.5 NS
Hematocrit % 28.40.7 30.40.7 NS
iPTH pg/mL 425.1159.0 347.0109.0 NS
Kt/V 1.60.3 1.60.2 NS
iPTH is serum intact parathyroid hormone level; Kt/V is dialysis dosage of
urea kinetic modeling calculated by Daugirdas’ formula. All data are presented
as mean  SEM or ratio.
prepared a Holter ECG recorder in all patients while
receiving hemodialysis. The Holter ECG signal was re-
corded during the whole duration of hemodialysis using
an Oxford solid-state 3-channel recorder (Medilog Hol-
ter recorders; Oxford Instruments, Fremont, CA, USA).
By detecting the QRS complex using Excel software
version 2.0 (Microsoft Corp., Redmond, WA, USA), the
signals were automatically processed on the Oxford laser
Holter scanner to perform heart rate variability analysis.
Spectral analysis of HRV was performed every 5 minutes
using the Welch method on short-lasting heart rate trac-
ers. We carried out heart rate variability analysis ac-
cording to the recommendations of the task force of the
European Society of Cardiology and the North Ameri-
can Society of Pacing and Electrophysiology [10]. We
performed power spectral analysis using Fast Fourier
transformation for the Holter ECG signals. Low-frequency
(LF, 0.040.15 Hz) components, high-frequency (HF,
0.150.4 Hz) components, and the ratio of LF/HF were
measured. The ratio of LF/HF (power index) was consid-
ered to mirror sympathovagal balance and reflect the
sympathetic modulations [7, 11, 12].
Systemic vascular resistances
ECGs were performed at the end of hemodialysis using
a Sonos 5500 (Hewlett Packard; Agilent, Palo Alto, CA,
USA) echocardiographic system. M-mode measurements
were obtained according to American Society of Echocardi-
ography standards. We measured aortic annulus dimension
(Ao) and aortic Doppler velocity time integral (AoVTI).
Systolic (SBP) and diastolic (DBP) blood pressures were
obtained using arm cuff measurements of a sphygmoma-
nometer immediately prior to the echocardiograms. The
SVR were determined by the following equations:
MBP (mm Hg)  (SBP  2DBP)/3
SV (mL)  AoVTI  Ao2/4
CO (L/min)  SV  HR/1000
SVR  MBP/CO
Table 2. Results of vibration perception threshold measurements
and nerve conduction studies
Hypotension- Control
prone group group P value
Vibrameter
VPT-IF VU 2.20.3 1.50.2 0.05
VPT-GT VU 4.70.7 3.10.4 0.05
Nerve conduction study
Peroneal nerve
MNCV m/s 41.21.8 40.03.7 NS
CMAP mV 5.00.7 6.10.7 NS
DL ms 4.40.2 4.10.1 NS
Tibial nerve
MNCV m/s 42.01.9 42.71.3 NS
CMAP mV 10.01.1 12.91.0 NS
DL ms 4.60.2 4.50.1 NS
Sural nerve
SNAP lV 12.21.6 13.11.8 NS
DL ms 3.10.2 3.20.1 NS
VPT-IF and VPT-GT, vibration perception threshold of index finger and great
toe, respectively; VU, vibration unit; MNCV, motor nerve conduction velocity;
CMAP, amplitude of compound motor action potential; SNAP, sensory nerve action
potential; DL, distal latency to the onset. All data are presented as mean  SEM.
Statistics
All data were expressed as mean  SEM or propor-
tions as appropriate. To analyze the data, we applied
unpaired t tests to test the differences between groups
and repeated measure of analysis of variance (ANOVA)
to examine the differences among serial measurements
within groups. Once a difference was found in repeated
measure of ANOVA, the Student-Neuman-Keuls test
was used for pair-wise comparisons. Fisher’s exact test
was used to analyze proportional data. All p levels were
two-tailed and values less than 0.05 were considered
significant. Statistics were conducted using SPSS 8.0.1C
(SPSS, Inc., Chicago, IL, USA).
RESULTS
The general characteristics of the hypotension-prone
and control groups are shown in Table 1. There were
no significant differences in age, sex, dialysis duration,
body weight, body height, ultrafiltration rate of hemodi-
alysis, dialysis dosage, serum prealbumin, hematocrit,
and plasma intact parathyroid hormone (iPTH) values
between these two groups.
Table 2 shows the results of VPT measurements and
NCV studies. According to NCV studies, there were no
significant differences in the prevalence of peripheral
neuropathy (55% in hypotension-prone group and 36%
in the control group). There were also no significant differ-
ences in the parameters, including MNCVs, CMAPs, and
DLs of the peroneal nerve and tibial nerve, and SNAP
and DL of the sural nerve, between the hypotension-
prone and the control groups. However, the VPT mea-
surements of the index finger and the great toe were
significantly higher in the hypotension-prone group than
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Fig. 1. Power index (LH/HF ratio), mean arterial pressure, and heart
rate during dialysis of hypotension-prone patients and controls. *P 
0.05 and **P 0.005 for hypotension-prone patients vs. controls; ***P
0.05 vs. baseline values of respective groups. LF/HF ratio is the ratio
between low-frequency and high-frequency power of heart rate vari-
ability.
that in the control group (2.2  0.3 vs. 1.5  0.2 VU,
4.7  0.7 vs. 3.1  0.4 VU, respectively; P  0.05).
Figures 1A and 1B show the changes of mean arterial
pressure and heart rate during hemodialysis, respec-
tively. Compared with the control group, the hypoten-
sion-prone group had a significantly lower mean arterial
pressure during hemodialysis, except for the basal value;
the levels measured between hour 2 and 3 were signifi-
cantly lower than that at hour 0 (70  3 and 78  4 vs.
90  4 mm Hg; both P  0.05). On the contrary, the
control group showed no change in mean arterial pres-
sure throughout the whole dialysis session. The data for
frequency domain of spectral analysis of heart rate vari-
ability are shown in Table 3. There were no significant
differences of HF or LF between the two groups, except
for the basal level of HF. The power index of heart rate
Table 3. Results of the heart rate variability
Hypotension- Control
prone group group P value
LF before dialysis 684.8245.0 299.8112.1 NS
LF 1st hour 387.8156.8 414.7125.8 NS
LF 2nd hour 491.3211.2 560.1175.3 NS
LF 3rd hour 380.5174.1 659.3244.3 NS
LF 4th hour 272.8141.2 486.4177.4 NS
HF before dialysis 808.5275.0 172.551.6 0.05
HF 1st hour 439.5222.7 211.457.0 NS
HF 2nd hour 327.8137.7 284.689.3 NS
HF 3rd hour 256.0125.5 301.0116.8 NS
HF 4th hour 198.759.3 193.075.7 NS
Abbreviations are: LF, low-frequency power index unit; HF, high-frequency
power index unit. All data are presented as mean  SEM.
Table 4. Hemodynamic characteristics
Hypotension- Control
Characteristics prone group group P value
SBP mm Hg 117.28.3 131.67.8 NS
DBP mm Hg 62.85.7 77.02.7 NS
HR beats/min 85.67.1 72.43.4 NS
Aortic annulus (Ao) cm 2.00.1 1.90.1 NS
AoVTI cm/beat 23.12.7 22.01.5 NS
CO L/min 6.51.2 4.50.5 NS
SVR Wood units 13.71.8 22.32.6 0.05
Abbreviations are: SBP, systolic blood pressure; DBP, diastolic blood pres-
sure; HR, heart rate; AoVTI, aortic Doppler velocity time integral; SV, stroke
volume; CO, cardiac output; SVR, systemic vascular resistance. All data are
presented as mean  SEM.
variability is shown in Figure 1C. The hypotension-prone
group showed a significantly lower LF/HF ratio than that
in the control group from the beginning to the end of
hemodialysis. The serial measurements of the LF/HF ratio
rose progressively and reached a significantly higher level
at hour 4 in the control group (3.7 0.5 vs. 2.1  0.3; P
0.05), whereas in the hypotension-prone group, the LF/HF
ratio did not change significantly throughout the whole
course of hemodialysis, even when the mean arterial
pressure was significantly decreased. In addition, we also
found that the SVR was significantly lower in the hypo-
tension-prone group than in the control group (13.7 
1.8 vs. 22.3  2.6 Wood units; P  0.05) (Table 4).
DISCUSSION
Spectral analysis of the heart rate variability has been
proven to be a useful and noninvasive tool for monitoring
the variations of sympathovagal balance controlling heart
rate and vasomotor tone [7, 11–13]. The HF components
are of purely vagal origin, but there is controversy in
the interpretation of the LF components, which some
assumed to be markers of sympathetic modulation, but
others as reflections of both sympathetic and parasympa-
thetic controls [12, 14–16]. Thus, we used the LF/HF
ratio, the power index, as a surrogate of the sympathova-
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gal balance [17]. Although the VPT test has not been
commonly used to assess peripheral nervous function, it
has been reported to have a good correlation with the
clinical score of uremic neuropathy [12, 15]. In addition,
the intra-individual variation of the VPT test has also
been demonstrated to be acceptable and comparable
between normal and uremic patients [12]. Because the
VPT test is easily performed and easily tolerated by the
patient, the normal variation, as well as the reproducibil-
ity, can be properly defined, and the elevated values
are relevant and sufficiently specific for peripheral nerve
function, we used the VPT test in addition to the NCV
study to assess peripheral nervous function.
In our study, we found that the hypotension-prone
hemodialysis patients had lower basal levels and lesser
change of the power index, as well as lower systemic vascu-
lar resistance and higher vibration perception threshold.
Because fluid removal during ultrafiltration is a potent
stimulus for the sympathetic activity, we kept a constant
ultrafiltration rate in both groups throughout the whole
course of hemodialysis. The results of lesser changes of
the power index and lower systemic vascular resistance
suggested that under the similar stimulation, the auto-
nomic nervous system of the hypotension-prone patients
could not compensate adequately and would lead to he-
modynamic instability. This might be caused by a dysreg-
ulation of sympathetic activity or sympathovagal imbal-
ance. Furthermore, a lower basal LF/HF ratio was found
in the hypotension-prone patients in our study, which is
consistent with the results of previous reports [18, 19].
This might imply that the hypotension-prone patients have
chronically reduced efficiency of the autonomic system.
Around 10% to 80% of uremia patients have been re-
ported to have peripheral polyneuropathy [20, 21]. How-
ever, the results of previous reports in the literature about
damages that occurred in somatic and autonomic ner-
vous systems of uremic patients are inconsistent [5, 6].
Most of these studies were performed using results of
the NCV tests. Compared with the VPT measurement,
results of the NCV studies are less sensitive to detect
subtle changes in peripheral nervous system. Theoreti-
cally, any part of the tract, including the receptor, Paci-
nian corpuscles, the very distal portion of the A	 nerve
fibers, the dorsal column, and the sensory cortex could
be assessed efficiently using the VPT test, but the NCV
study could only be used to evaluate more proximal
portions of the nerves. In addition, normal vibration
sensations depend on synchronous volleys of impulse
trains in a large number of A	 nerve fibers, but the NCV
study evaluates only one nerve at a time. Therefore,
dysfunction of the axonal membrane or of the receptor
might desynchronize the impulse trains without dis-
playing abnormalities in a single nerve test. Because
uremic polyneuropathy is predominantly dying-back ax-
onal degeneration [22], the test of the VPT seems to be
a sensitive and easy method to detect peripheral neurop-
athy in hemodialysis patients. Therefore, it is not surpris-
ing that we found parallel damages of autonomic nervous
system and vibration perception threshold, but not nerve
conduction velocity.
Although we did not perform nerve biopsies among
our patients, the impairment of the VPT due to segmen-
tal demyelinization of the afferent nerve fibers has been
demonstrated in histopathologic studies in diabetics [23],
as well as in uremic patients [24].
CONCLUSION
We found that more severe damage occurred in the
autonomic nervous system in the hypotension-prone
patients, which might be the cause of intradialytic hypo-
tension. In addition to the autonomic dysfunction, the
vibration perception threshold was higher in the hypo-
tension-prone patients, which indicated a more severe
generalized polyneuropathy in these patients.
ACKNOWLEDGMENTS
This work was supported by grants from Kaohsiung Veterans Gen-
eral Hospital VGHKS89-42 to Dr. Kang-Ju Chou, and VGHKS90-26
to Dr. Hua-Chang Fang.
Reprints requests to Kang-Ju Chou, M.D., Division of Nephrology,
Department of Medicine, Kaohsiung Veterans General Hospital, 386
Ta-Chung 1st Rd, Kaohsiung, Taiwan 813.
E-mail: kjchou@isca.vghks.gov.tw
REFERENCES
1. Schreiber MJ Jr: Clinical case-based approach to understanding
intradialytic hypotension. Am J Kidney Dis 38(Suppl 4):S1–S10,
2001
2. Daugirdas JT: Pathophysiology of dialysis hypotension: An up-
date. Am J Kidney Dis 38(Suppl 4):S11–17, 2001
3. Converse RL Jr, Jacobsen TN, Jost CM, et al: Paradoxical with-
drawal of reflex vasoconstriction as a cause of hemodialysis-induced
hypotension. J Clin Invest 90:1657–1665, 1992
4. Ligtenberg G, Blankestijn PJ, Boomsma F, Koomans HA: No
change in automatic function tests during uncomplicated haemodi-
alysis. Nephrol Dial Transplant 11:651–656, 1996
5. Ogura T, Makinodan A, Kubo T, et al: Electrophysiological
course of uraemic neuropathy in haemodialysis patients. Postgrad
Med J 77:451–454, 2001
6. Vita G, Bellinghieri G, Trusso A, et al: Uremic autonomic neu-
ropathy studied by spectral analysis of heart rate. Kidney Int 56:232–
237, 1999
7. Malik M: Heart rate variability. Standards of measurement, physi-
ological interpretation, and clinical use. Circulation 93:1043–1065,
1996
8. Nielsen VK: The peripheral nerve function in chronic renal failure.
IV. An analysis of the vibratory perception threshold. Acta Med
Scand 191:287–296, 1972
9. Tegner R, Lindholm B: Vibratory perception threshold compared
with nerve conduction velocity in the evaluation of uremic neuropa-
thy. Acta Neurol Scand 71:284–289, 1985
10. Klima RR, Weigand AH, DeLisa JA: Nerve conduction studies
and vibratory perception thresholds in diabetic and uremic neurop-
athy. Am J Phys Med Rehabil 70:86–90, 1991
11. Akselrod S, Gordon D, Madwed JB, et al: Hemodynamic regula-
tion: Investigation by spectral analysis. Am J Physiol 249:H867–
875, 1985
Lee et al: Generalized peripheral neuropathy in intradialysis hypotension1094
12. Askelrod S, Gordon D, Ubel FA, et al: Power spectrum analysis
of heart rate fluctuation: A quantitative probe of beat-to-beat
cardiovascular control. Science 213:220–222, 1981
13. van Ravenswaaij-Arts CM, Kollee LA, Hopman JC, et al: Heart
rate variability. Ann Intern Med 118:436–447, 1993
14. Kamath MV, Fallen EL: Power spectral analysis of heart rate
variability: A noninvasive signature of cardiac autonomic function.
Crit Rev Biomed Eng 21:245–311, 1993
15. Montano N, Ruscone TG, Porta A, et al: Power spectrum analysis
of heart rate variability to assess the changes in sympathovagal
balance during graded orthostatic tilt. Circulation 90:1826–1831,
1994
16. Appel ML, Berger RD, Saul JP, et al: Beat to beat variability
in cardiovascular variables: Noise or music? J Am Coll Cardiol
14:1139–1148, 1989
17. Malliani A, Lombardi F, Pagani M: Power spectrum analysis of
heart rate variability: A tool to explore neural regulatory mecha-
nisms. Br Heart J 71:1–2, 1994
18. Takahashi H, Matsuo S, Toriyama T, et al: Autonomic dysfunc-
tion in hemodialysis patients with persistent hypotension. Nephron
72:418–423, 1996
19. Cavalcanti S, Severi S, Chiari L, et al: Autonomic nervous func-
tion during haemodialysis assessed by spectral analysis of heart-
rate variability. Clin Sci 92:351–359, 1997
20. Asbury AK: Uremic neuropathy, in Peripheral Neuropathy, edited
by Dyck PJ, Thomas PK, Lambert EH, Philadelphia, WB Saun-
ders, 1978, pp 982–990
21. Bazzi C, Pagani C, Sorgato G, et al: Uremic polyneuropathy: A
clinical and electrophysiological study in 135 short- and long-term
hemodialyzed patients. Clin Nephrol 35:176–181, 1991
22. Dyck PJ, Johnson WJ, Lambert EH, O’Brien PC: Segmental
demyelination secondary to axonal degeneration in uremic neurop-
athy. Mayo Clin Proc 46:400–431, 1971
23. Thomas PK: Diabetic neuropathy: Morphological aspects. Proc R
Soc Med 60:145, 1967
24. Forno L, Alston W: Uremic polyneuropathy. Acta Neurol Scand
43:640–654, 1967
